Time For The Newer Biotech Companies To Wake Up?
Michele Schneider | Sep 20, 2020 05:34AM ET
With companies like Pfizer (NYSE:PFE) giving possible hope for an end of year vaccine and a recent gap up in IBB (Nasdaq Biotechnology ETF), now could be a good time to keep an eye on newer issues in this sector.
Large amounts of buying came into IBB Friday. The price initially broke Thursday’s low of 133.91, only to rally back and close over the 50-DMA.
If it can hold this level as support, heading back to the July 7th high of 146.53 looks increasingly possible.
Above we have BEAM Therapeutics. Note you won’t find the 200-DMA on the chart because this company has only been public since February.
On September 4th a double bottom was formed and now BEAM is almost back to its high of 31.00.
Watching for a break of these levels could be a potential active trade with a tight risk.
Also, I talked about BridgeBio Pharma (NASDAQ:BBIO) when it was trading around 38. As an active trade heading to new highs, this has great potential and a huge amount of strength on the Real Motion Indicator.
While still great for an active trade with tight risk, keeping this one on the radar for a pullback or some consolidation could be worth waiting for.
Burning Rock Biotech (NASDAQ:BNR) has had a clean correction pulling back to the 18 range.
Get The News You Want
A confirmation over the 50-DMA, which should coincide with a break of the recent high of 24.89 on August 28th, is where I’m currently watching.
These new issues are exciting to watch, but one other mention is based on late-breaking news when President Trump announced all Americans will have a vaccine available to them by April 2021.
Moderna (NASDAQ:MRNA), closed just shy of its 50-DMA late Friday. As the potential leader of getting the alleged vaccine, keep your eyes on this stock as well.
We all need hope and the biotech space could very well be the next leader as computer technology takes a breather.
S&P 500 (SPY) Closed below the 50-DMA for an unconfirmed caution phase. If can’t clear back over the 50 322-324 is the target.
Russell 2000 (IWM) Huge volume, this has taken leadership. 151, 50-DMA Support Resistance 156
Dow (DIA) 274 Key Support. 280 Resistance
Nasdaq (QQQ) Confirmed caution phase. 260 support and target
KRE (Regional Banks) Needs to hold 36 Support. Looking for a move over 50 and 10 DMA
SMH (Semiconductors) Marginally broke the 50-DMA for an unconfirmed caution phase.
IYT (Transportation) 200 key support
IBB (Biotechnology) Back to an unconfirmed bullish phase.
XRT (Retail) As the modern family is doing better, 49.30 the 50-DMA is key support
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.